Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...
The way some pregnancy apps handle weight can be triggering to people with a history of disordered eating. Here's what to do ...
The European Medicines Agency backed the use of Novo Nordisk's NOVOb.CO popular drug Wegovy to help ease heart failure in ...
Dr. Orbeck’s practice is dedicated to advancing the integration of functional medicine with traditional healthcare, providing ...